论文部分内容阅读
本刊讯根据药品不良反应评估结果,为控制临床用药风险,保障公众用药安全,经研究,决定对醒脑静注射液说明书增加警示语,并对【不良反应】【禁忌】【注意事项】项进行修订,具体修订要求如下:1.应增加警示语,内容如下,警示语:本品不良反应包括过敏性休克,应在有抢救条件的医疗机构使用,使用者应是具备治疗过敏性休克等严重过敏反应资质或接受过过敏性休克抢救培训的医师,用药后出现过敏反应或严重不良反应立即停
According to the results of ADR evaluation, in order to control the risk of clinical medication and ensure the safety of public use of drugs, the study decided to increase the caution on Xingnaojing Injection and set forth the guidelines for adverse reactions, taboo, and precautions The specific revision requirements are as follows: 1. Warning signs should be added, as follows, the warning signs: This product adverse reactions include anaphylactic shock, should be used in medical institutions with the rescue conditions, the user should have the treatment of anaphylactic shock, etc. Severe allergic reaction qualifications or received allergic shock rescue training physicians, allergic reactions or serious adverse reactions immediately after treatment stop